Recent Advances in Tuberculosis and Nontuberculous Mycobacteria Lung Disease / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 251-255, 2013.
Article
in English
| WPRIM
| ID: wpr-59652
ABSTRACT
Tuberculosis (TB) is one of the largest health problems in the world today. And the incidence of nontuberculous mycobacteria (NTM) lung disease appears to be increasing worldwide. Recently, an automated, nucleic acid amplification assay for the rapid detection of both Mycobacterium tuberculosis and rifampin resistance was developed (Xpert MTB/RIF). And fixed-dose combinations of anti-TB drugs and linezolid have been introduced in the treatment of TB. And new NTM species, named Mycobacterium massiliense, which is very closely related to Mycobacterium abscessus was reported. In this review, these recent advances in the diagnosis and treatment of TB and clinical characteristics of M. massiliense lung disease are discussed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Rifampin
/
Tuberculosis
/
Incidence
/
Oxazolidinones
/
Nucleic Acid Amplification Techniques
/
Linezolid
/
Lung
/
Lung Diseases
/
Acetamides
/
Mycobacterium
Type of study:
Incidence study
/
Prognostic study
Language:
English
Journal:
Tuberculosis and Respiratory Diseases
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS